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Nerve conduit is one of strategies for spine cord injury (SCI) treatment. Recently, studies showed that biomaterials could guide 
the neurite growth and promote axon regeneration at the injury site. However, the scaffold by itself was difficult to meet the 
need of SCI functional recovery. The basic fibroblast growth factor (bFGF) administration significantly promotes functional 
recovery after organ injuries. Here, using a rat model of T9 hemisected SCI, we aimed at assessing the repair capacity of im-
plantation of collagen scaffold (CS) modified by collagen binding bFGF (CBD-bFGF). The results showed that CS combined 
with CBD-bFGF treatment improved survival rates after the lateral hemisection SCI. The CS/CBD-bFGF group showed more 
significant improvements in motor than the simply CS-implanted and untreated control group, when evaluated by the 21-point 
Basso-Beattie-Bresnahan (BBB) score and footprint analysis. Both hematoxylin and eosin (H&E) and immunohistochemical 
staining of neurofilament (NF) and glial fibrillary acidic protein (GFAP) demonstrated that fibers were guided to grow through 
the implants. These findings indicated that administration of CS modified with CBD-bFGF could promote spinal cord regener-
ation and functional recovery. 
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After spinal cord injury (SCI), axons in the central nervous 
system are damaged and show limited regeneration because 
of an adverse environment such as inflammation, ischemia, 
lipid peroxidation, or glial scarring [1,2]. In order to create 
desirable environment for axons regeneration, people have 
focused on studies bridging and guiding the axon growth to 
the correct direction with natural or synthetic scaffold, aim-
ing to reduce various secondary injury and glial scar for-
mation. In addition, growing evidence showed beneficial 
effects of neurotrophic factors on spinal cord regeneration 
[3,4]. 
Collagen material has already been applied in clinic be-
cause of its biodegradability, biocompatibility, low toxicity 
and antigenicity [5,6]. It has also been used widely in tissue 
engineering and regeneration medicine due to its nano-level 
 Shi Q, et al.   Sci China Life Sci   February (2014) Vol.57 No.2 233 
linear structure similar to extracellular matrix [79]. As a 
novel nerve guidance material, collagen scaffold (CS) can 
guide the orientated growth of axons after SCI in rabbits 
[10]. It also binds to neurotrophic factors as a drug delivery 
system to support axonal growth along its fibers to form 
correct neural connection, thus enhancing functional recov-
ery in rat SCI models [7,11].  
Basic fibroblast growth factor (bFGF) is a member of the 
fibroblast growth factor family and highly expressed in 
neuronal tissues. In rodents, a significant increase of bFGF 
expression was found after many central nervous system 
diseases including SCI. It has been shown that bFGF plays 
an important role in neuronal axon regeneration and repair 
after spinal cord injury, especially in the early stages of in-
jury [12]. There also existed more bFGF positive cells in rat 
spinal cord after contusion injury than those in normal spi-
nal cord, indicating that bFGF might be beneficial for spinal 
cord repair [13]. Recent studies have also shown that ad-
ministration of bFGF following SCI is neuroprotective and 
significantly promotes functional recovery [14,15]. But be-
cause of its short half-life time and rapid diffusion in body 
[16], avoidance of the rapid diffusion became necessary. In 
order to limit its diffusion, a collagen binding domain (CBD) 
was designed to fuse bFGF (CBD-bFGF) with collagen in 
extrahepatic bile duct regeneration [17] and uterine horn 
regeneration [16]. 
In this study, the lateral 3 mm hemisection SCI of rat 
model was made, and CS fused with CBD-bFGF (CS/bFGF) 
was implanted into the hemi-transected gap to investigate 
the effects of the scaffolds combined with growth factors on 
the neural recovery after SCI. 
1  Materials and methods 
The guideline for the Care and Use of Laboratory Animals 
of the US National Institutes of Health (NIH) were followed 
during all the experimental procedures, and the experi-
mental protocol was approved by the Animal Research 
Committee of Soochow University. 
1.1  Production of CS and CBD-bFGF 
CS was prepared from bovine aponeurosis as previously 
described [14]. Briefly, fresh bovine aponeurosis was sepa-
rated from muscles, and then was cut into proper size. The 
residual muscles, connective tissues and fats were further 
removed from the aponeurosis. Subsequently, the cellular 
components and soluble proteins were extracted, freeze- 
dried and cut into the 2 mm×2 mm×3 mm bundles.  
CBD-bFGF protein was prepared [18]. The expression 
vectors of CBD-bFGF were transformed into BL21 (DE3) 
strain of E. coli, induced with isopropyl β-D-thiogalacto- 
pyranoside (IPTG). Proteins of CBD-bFGF containing six 
histidine tags were purified, concentrated and weighted.  
1.2  SCI modeling and grouping 
Healthy male adult Sprague-Dawley (SD) rats with a body 
weight of 240–260 g were used for surgical procedures. 
Rats were anesthetized with sodium pentobarbital (50 mg 
kg1 body weight) and the model of a T9 half-cut spinal 
cord column was made. After shaved and cleaned with a 
betadine solution, the skin was incised and the muscle tissue 
was dissected to expose the T9 vertebral body. Laminecto-
my was performed at T9 to expose the dura-covered spinal 
cord. After a longitudinal incision was made in the dura to 
expose the posterior median sulcus, the left half of the spi-
nal cord was cut at T9, followed by the removal of a 3 mm 
hemicord segment, and the extent of the lesion was defined 
by a 3 mm width scissor-cut scrip (Figure 1A–C). All rats 
were randomly divided into four groups: (i) sham-operated 
group: laminectomy without SCI; (ii) control group: 
half-cut spinal cord column was made without treatment; 
(iii) CS-treated group: a 2 mm×2 mm×3 mm bundle of CS 
scaffold was implanted into hemi-transected gap; (iv) 
CS/bFGF group: a bundle of 2 mm×2 mm×3 mm. CS fused 
with CBD-bFGF (2 μg/10 μL/bundle) was implanted into 
hemi-transected gap. Then, the muscle layers and the skin 
were sutured individually. After surgical procedures, animal 
post-operative care was required including prevention of 
autophagia and infection, proper bladder and bowel care. In 
30 d after SCI, the survival curve was made according to the 
time of death. 
1.3  Exclusion criteria 
Spinal cord section in rats would result in a little sparing of 
ventral white matter, which was enough for the rats to 
spontaneously recover hindlimb locomotion [19]. As previ-
ously described, rats using the ipsilateral hindlimb to bear 
weight and walk at 1 d postoperation were excluded from 
the study [20]. 
1.4  Basso-Beattie-Bresnahan (BBB) test 
Hindlimb locomotor function was assessed with the 21- 
point (BBB) scale [21]. The tests were performed before the 
operation and at 1 week intervals after SCI for 8 weeks. 
Animals were placed individually on open field and allowed 
to move freely for 5 min. Two experienced observers who 
were blinded to the groups evaluated the performance ac-
cording to the BBB scale, ranging from 0 (no limb move-
ment or weight support) to 21 (normal locomotion). 
1.5  Footprint analysis 
Four and eight weeks after operation, footprint analysis was 
performed in order to assess body weight support and limb 
coordination, respectively. The fore- and hind-paws of the 
rats were inked with red and blue, respectively, and the  
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footprints were recorded on white paper during walking on 
a straight runway of 1 m length and 7 cm width. The base of 
support was determined by measuring perpendicular dis-
tance between the centers of left and right hind limbs. Stride 
length was defined by distance between the footprint centers 
of ipsilateral adjacent footprints, through which interlimb 
coordination also can be assessed. The angle of hindpaw 
rotation was measured as the angle formed between the line 
which joins the print of the third digit and the central pad 
and the walking direction line [19,22]. The average of five 
sequential steps was measured for every animal. Two ob-
servers were blinded to all groups. 
1.6  Histology and immunohistochemistry 
The histological evaluation was performed at four and eight 
weeks post injury. After the rats were euthanized, pieces of 
spinal cord from T7-T11 were dissected and fixed in 4% 
paraformaldehyde. Longitudinal or cross-sectional spinal 
cord sections were cut and stained with hematoxylin and 
eosin (H&E). For immunohistochemistry, the spinal cord 
sections were incubated with antibodies against neurofila-
ment(NF) and glial fibrillary acidic protein(GFAP) (mouse 
anti-NF and mouse anti-GFAP, Santa Cruz Biotechnology, 
USA). Using a digital microscope camera (Zeiss, German), 
the sections of spinal cord were imaged at 50× and 200× 
magnification.  
1.7  Statistical analysis 
All the data were presented as mean±SEM. Single compar-
isons were analyzed using unpaired two-tailed student’s 
t-test. Data from more than two groups was compared by 
one-way analysis of variance (ANOVA). Statistical analysis 
was performed using GraphPad Prism 5 for Windows.  
2  Results 
2.1  SCI and survival analysis  
After the left hemicord was completely transected at T9  
level in this experiment, the function of hindlimb ipsilateral  
to the injury was impaired severely, with milder effects on 
the function of contralateral hindlimb, as described in a pre-
vious study [18]. Figure 1D shows rat dragged the hindlimb 
ipsilateral to the injury at the first-week postinjury (seven 
animals with incomplete left hemisection were excluded 
from the experiment: two from control group, three from CS 
group, and two from CS/bFGF group). 
At the 30 d after SCI, the rate of death was high in both 
control group and CS-treated groups. The survival curve 
showed that CS/bFGF group had a significantly higher sur-
vival rate than that of control and CS-treated groups, with 
the control group had the lowest survival rate. There was no 
death in the sham group (Figure 2). 
2.2  BBB score 
Hindlimb movements were evaluated using the 21-point 
BBB rating Scale once a week after SCI for eight weeks. 
For the sham group, the BBB score was around 21 (n=11), 
indicating that there was no harm to the spinal cord. Alt-
hough the SCI animals showed a gradual recovery in 
hindlimb locomotor function during the eight-week period, 
BBB score increased more rapidly in the first four weeks 
and then reached a plateau in each SCI group. In addition, 
the left hindlimb function in CS/bFGF group recovered 
faster and better than that of the control group and 
CS-treated groups. At the end of the eighth week, the BBB 
scores in both the CS/bFGF (15.67±0.83, n=9) and CS 
(13.00±0.71, n=8) groups were significantly higher than 
that in the control group (10.89±0.42, n=9) (P<0.05 for 
CS/bFGF group vs. CS group, P<0.05 for CS/bFGF group 
vs. control group, and P<0.05 for CS group vs. control 
group, Figure 3A). There was no significant difference in 
BBB scores of the right hindlimb between the SCI groups in 
the whole experiment processes (Figure 3B), suggesting a 
good uniformity for the SCI models. 
2.3  Footprint analysis 
Footprint analysis of the left ipsilateral hindlimb of SCI 
groups was summarized in Figure 4. At four and eight 
weeks after SCI, the sham-operated group showed the same 




Figure 1  Surgical procedures of hemisected SCI model at T9. A, The white arrow indicates the hemisection site. B, The white arrow indicates the CS, and 
the extent of the lesion was defined by a 3 mm scissor-cut scrip. C, The hemisection space that was filled with the CS. D, A rat dragged the hindlimb ipsilat-
eral to the injury at the first-week postinjury. 
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Figure 2  The survival curve of the surgical groups 30 d after the opera-
tion. Sham group (n=25); control group (n=25); CS group (n=23); CS/ 
bFGF (n=19). 
and hindlimb. The base of support (3.4±0.06 cm) and angle 
of rotation (1.8±0.19°) were all minimum in the sham-  
operated group (Figure 4A). At four and eight weeks, the 
base of support of the CS/bFGF group was obviously re-
duced compared to that of the CS group and control groups 
(Figure 4B, P<0.05), and it was even approximate to that of 
the sham-operated group at eight weeks after SCI (Figure 
4B, P>0.05). In addition, toe dragging was more serious in 
the control and CS-treated groups than that in the CS/bFGF 
group (Figure 4C, P<0.01 vs. control, P<0.05 vs. CS). The 
differences of the stride lengths of fore- and hindlimb in the 
SCI groups revealed that interlimb coordination was signif-
icantly improved in the CS/bFGF group compared to that in 
the CS-treated and control groups at four and eight weeks, 
respectively (Figure 4D and 4E, P<0.05 vs. control, P<0.05 
vs. CS). Relative to the control and CS-treated groups, the 
CS/bFGF group showed smaller angle of rotation (Figure 
4F and 4G, P<0.05 vs. control, P<0.05 vs. CS).  
Although consistent improvement could be seen in stride 
length, base of support and angle of rotation in the right 
contralateral hindlimb all the time, no significant differ-
ences were found between the SCI groups, indicating the 
good uniformity of the SCI models. 
2.4  Morphological and immunohistochemical study 
For macroscopical evaluation, a large coloboma was formed  
in the spinal cord in the control group. In contrast, the col-
oboma was completely filled with the scaffold in the CS- 
treated and CS/bFGF group. Moreover, in the CS-treated 
group, there were more scar tissues at the hemisection site 
than those of the CS/bFGF group (Figure 5).  
At four and eight weeks, the density of linear fibrous tis-
sues and cell infiltration were significantly increased in and 
around the scaffold of CS/ bFGF group compared to those 
of the control and CS-treated groups (Figure 6). The H&E 
staining also showed that CS degraded gradually with the 
time went on. 
The CS/bFGF group showed higher NF-positive neural 
fiber density than that of the control and CS group. Besides, 
the NF-positive neural fibers could extend into the scaffold, 
and grew along with the direction of CS. The NF-positive 
fibers were hardly observed in and around SCI sites in the 
control and CS-treated group (Figure 7).  
GFAP+ astrocytes were present around the hemi-   
transected site in all SCI rats. At four and eight weeks after 
the surgery, the number of GFAP+ cells was lower in the 
CS/bFGF group compared to that of the control and 
CS-treated groups, with the highest number present in the 
control group (Figure 8). 
3  Discussion 
SCI often results in irreversible dysfunction and disability. 
Treatment for SCI still remains limited to promote the ax-
onal regeneration. Recently, there have been different ap-
proaches proposed to improve SCI repair such as biomolec-
ular, cellular, and biomaterial-based therapies [23,24]. 
However, it is unlikely that a single strategy will be ade-
quate to treat SCI. Nerve conduit is one of strategies for SCI 
treatment. It is hoped that some combination strategies 
would promote spinal cord axons to stretch through the glial 
scar and recreate connections. In this study, we attempted to 
use a combined implantation of scaffolds fused with the 
growth factor to repair SCI. 
Among various biomaterials, CS has shown great devel-
opment potential to repair the SCI because of its good bio-
compatibility and low antigenicity [6]. Currently, the re- 
 
Figure 3  Hindlimb movements were evaluated using the 21-point BBB rating scale after SCI for eight weeks. A, The BBB score of left hindlimb. B, The 
BBB score of the right hindlimb. All the data were presented as mean±SEM. *, P<0.05. 





Figure 4  Footprint analysis at four and eight weeks after SCI. A, Photoes of rat fore-(inked in red) and hindlimb (inked in blue) coordination and toe 
spreading. B, Base of support scored by centremeters. C, The frequency of toe dragging. D and E, The stride length of fore- and hindlimb at four and eight 
weeks, respectively. F and G, The angle of rotations at four and eight weeks, respectively. Sham group (n=10); control group (n=9); CS group (n=8); 
CS/bFGF group (n=9). *, P<0.05; **, P<0.01. 
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Figure 5  Dorsal view of the rat spinal cords at eight weeks after surgery. Triangular arrow indicated a large coloboma in the control group, white and black 
arrow indicated the coloboma filled with the scaffold in the CS and CS/bFGF group, respectively. 
 
Figure 6  H&E staining for injury lesions of spinal cords at four and eight weeks after operation. Scale bar, 500 μm. 
generated axons often lengthen blindly and can not reach at 
a proper position. The lack of contact guidance in transected 
axons has become one of the main problems. The CS may 
solve this problem because of its structure and good 
cell-adhesion [10]. It can provide not only a physical sup-
port for axon extension, but also a delivery system for cyto-
kines and growth factors [18].  
bFGF plays an important role in functional recovery after 
SCI [14]. Besides the role in promoting axon regeneration, 
administration of bFGF has been reported to have neuro-
protective and improved behavioral effects in vivo after SCI 
[2527]. Recent experiments showed that bFGF could in-
hibit apoptosis and increase the survival of neurons in injury 
site of the spinal cord [28,29]. However, the bioactivity of 
bFGF could rapidly be cleared from the tissue [18]. bFGF 
fused on CS through collagen binding domain may offer a 
strategy to retain high-enough concentration in localized 
lesions and work on the generation of neurons after SCI 
[16,17].  
In order to test the effect of the implantation system, we 
established the lateral hemisection SCI rat model in this 
study. After the removal of a 3 mm hemicord segment, the 
damages were serious and it was impossible for the rostral 
nerve fibers to stretch across the injury gap due to the lack 
of support. According to open field BBB analyses of the 
ipsilateral hindlimb, the function of hindlimb ipsilateral to 
the injury was impaired severely after the operation; mean-
while the contralateral hindlimb also was affected inevitably. 
At the early stage of post-operation, especially in the first 
three weeks, the rate of death was high in the control group. 
These animals might die from number of causes, such as 
blood loss, neurogenic pulmonary oedema, lung infection, 
urinary infection and retention, or systemic inflammatory 
response syndrome (SIRS) [30]. The outcome was better in 
the CS- and CS/bFGF-treated groups than in the control 
group. Moreover, the rate of the death and the neuronal 
function after SCI in the CS/bFGF-treated group was sig-
nificantly improved compared to those of the CS-treated 
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Figure 7  Immunohistochemical staining of neurofilament(NF) for spinal cords at four and eight weeks after operation.  
 
Figure 8  Immunohistochemical staining of glial fibrillary acidic protein (GFAP) for spinal cords at four and eight weeks after operation.  
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group. The degree of locomotor recovery of the CS/bFGF 
group was the highest among the SCI groups. The footprint 
analysis also showed the same trend in limb coordination 
and body weight support. The phenomenon might be related 
to the neuroprotective role of CS/bFGF implant and im-
provement of the systemic status function. BFGF can inhibit 
apoptosis and increase the survival of neurons, which may 
be the main mechanisms. BFGF activate some downstream 
signals, such as PI3K/Akt and ERK1/2 pathways, which are 
essential for the neuroprotective effect [44]. Particularly, the 
PI3K/Akt pathway is very important for mediating neuronal 
survival under conditions of glucolipotoxicity, inflammation, 
etc. [31,32]. 
Macroscopically, a large coloboma was formed in the 
injury spinal cord in the control group. As we expected, the 
coloboma was completely filled with the scaffold in the 
CS-treatd and CS/bFGF group. Nerve fiber regeneration 
was demonstrated by H&E and immunohistochemical 
staining. At the injury side of the spinal cord, there were 
more NF-positive neural fibers in the CS/bFGF implant than 
those in CS-only implant. This biopsy demonstrated that 
more fibers were guided to grow through the implants in 
CS/bFGF group than CS-only group. The combination of 
CS and bFGF through CBD might thus create a more suita-
ble microenvironment for nerve fiber regeneration. In con-
trast, axonal growth was hardly seen in the control group, in 
which the higher density of GFAP staining was present than 
that in other groups. Similar to the results of previous study, 
the CS treatment decreases the accumulation of glial scar at 
the lesion site [7]. All the data on functional analysis and 
histological staining indicated that CS/bFGF treatment was 
benificial to the neural generation after the lateral hemisec-
tion SCI.  
For the treatment of SCI, to lay the foundation for the 
environment permissive for axonal growth, bridging the 
hemicord gap has become one of the strategies to re-estab- 
lish neurological structures and functions. Tissue engineer-
ing may play an important role in restoring integrity and 
function of the injured spinal cord. The restoration effect of 
the implantation system (CS/bFGF) may have many com-
plicated mechanisms. In the early stage, CS not only could 
bridge the injury gap for axonal regeneration, but also may 
influence cell migration and act as a carrier for migrating 
stem cells (such as MSCs, NSPCs, et al.) [24]. Meanwhile, 
CS fused with bFGF through CBD could be avoided of the 
rapid diffusion of bFGF, which may be one of the important 
mechanisms to promote the growth of axons. In addition, as 
a common biodegradable material, CS fused with bFGF can 
release bFGF continuously during the recovery period after 
SCI [33]. In the future clinical applications, this implanta-
tion system probably will be considered to be used as a new 
delivery system of growth factors for SCI patients. 
In conclusion, this study shows that implantation of 
CS/bFGF into a semi-transected SCI rat model can guide 
axon growth at the injury site and promote obvious im-
provement in functional recovery. As a result, it could be a 
promising alternative system for the clinical application of 
SCI repair. 
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